Nova (NASDAQ:NVMI – Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of $2.08 per share and revenue of $210.10 million for the quarter. Nova has set its Q1 2025 guidance at 2.000-2.160 EPS.
Nova (NASDAQ:NVMI – Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The semiconductor company reported $1.78 earnings per share for the quarter, missing analysts’ consensus estimates of $1.82 by ($0.04). The firm had revenue of $194.77 million during the quarter, compared to analyst estimates of $186.50 million. Nova had a return on equity of 22.33% and a net margin of 27.33%. On average, analysts expect Nova to post $8 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Nova Stock Down 1.1 %
Nova stock opened at $193.88 on Wednesday. Nova has a 52-week low of $154.00 and a 52-week high of $289.90. The firm has a market capitalization of $5.68 billion, a price-to-earnings ratio of 33.78, a PEG ratio of 2.55 and a beta of 1.66. The firm has a 50-day moving average price of $195.21 and a two-hundred day moving average price of $206.83.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on Nova
About Nova
Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging.
Featured Articles
- Five stocks we like better than Nova
- 3 Warren Buffett Stocks to Buy Now
- 3 Mid-Cap Medical Stocks Outperforming the Market
- 3 Small Caps With Big Return Potential
- The Top-Ranked Insider Buys From April by Market Cap
- The 3 Best Blue-Chip Stocks to Buy Now
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Nova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova and related companies with MarketBeat.com's FREE daily email newsletter.